OPTIMIZATION OF THERAPY FOR ACS PATIENTS WITH PHARMACOTHERAPY

Sunday, March 9, 2025

7:00 PM - 8:45 PM ET

Moderator(s)

C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

No relationships to disclose
Neal S. Kleiman, MD, FACC, MSCAI

Medical Director, Cardiac Catheterization Laboratories
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas, United States

No relationships to disclose

Disclosure(s):

Marc Cohen, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

C. Michael Gibson, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)

Neal S. Kleiman, MD, FACC, MSCAI: Abbott Labs: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Medtronic: Consultant (Ongoing)